Sign in
CompletedNo phase

Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens

Key facts

Who runs it
Johnson & Johnson Surgical Vision, Inc.
Where
Bakersfield, Brecksville, Garden City, Houston, Jacksonville, San Antonio, Sioux City, and Sioux Falls, United StatesSee the 9 sites
Trial code
Status
Completed
People taking part
245 people enrolled
Started
3 Jun 2024
Ended
23 Apr 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Test IOL Model DEN00V
  • Control IOL Model DCB00
Record updated
24 August 2026

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • To be considered for enrollment in this study, patient must:
  • be at least 22 years old
  • have cataracts in both eyes
  • sign the written informed consent
  • be willing and able to comply with examination procedures
  • understand, read and write English to complete informed consent and questionnaires
  • be available for study follow-up visits EXCLUSION CRITERIA; Patient will not be eligible to take part in the study if:
  • currently participating in any other clinical study or have participated in a clinical study during the last 30 days
  • have a certain disease/illness, such as poorly controlled diabetes
  • have certain ocular conditions, such as uncontrolled pressure in the eye
  • taking medication that may affect vision
  • pregnant, plan to become pregnant during the study, or are breastfeeding

Where in United States

  • Empire Eye & Laser CenterBakersfield, United States
  • Cleveland Eye ClinicBrecksville, United States
  • OCLI VisionGarden City, United States
  • Berkeley Eye InstituteHouston, United States
  • Whitsett Vision GroupHouston, United States
  • Levenson Eye AssociatesJacksonville, United States
  • Parkhurst NuVisionSan Antonio, United States
  • Jones Eye CenterSioux City, United States
  • Vance Thompson VisionSioux Falls, United States

About the trial

What the trial wants to find out

Prospective, multicenter, bilateral, interventional, controlled, masked (sponsor, subjects, and evaluators), randomized clinical trial.

The 2 groups in the trial

  • Test IOLTreatment being tested

    DEN00V

    Treatment: Test IOL Model DEN00V

  • Control IOLExisting treatment, for comparison

    DCB00

    Treatment: Control IOL Model DCB00

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
24 August 2026